Harnessing Placebo Effects in Methadone Treatment

NACompletedINTERVENTIONAL
Enrollment

133

Participants

Timeline

Start Date

December 5, 2017

Primary Completion Date

July 31, 2020

Study Completion Date

July 31, 2020

Conditions
Opioid-use DisorderOpioid-Related Disorders
Interventions
BEHAVIORAL

Open-Label Placebo (OLP)

We are designating this as a behavioral intervention for two reasons: (1) the placebo pill is physiologically inert and is not classified under FDA regulations; and (2) other studies have demonstrated that the efficacy of the placebo pill is strongly dependent on the participants' anticipation of an effect. We are presenting the pill's efficacy in an open and transparent way to the participants, but using a positive frame. We feel that this qualifies the placebo pill use as a behavioral intervention, in the same general category as exercise or relaxation.

Trial Locations (1)

21201

Maryland Methadone Treatment Center, Baltimore

All Listed Sponsors
collaborator

University of Maryland, College Park

OTHER

lead

University of Maryland, Baltimore

OTHER

NCT02941809 - Harnessing Placebo Effects in Methadone Treatment | Biotech Hunter | Biotech Hunter